Hannah Cagney. Show Affiliations »
Abstract
Mesh： See more » Antineoplastic Agents/economicsAntineoplastic Agents/therapeutic useBiomedical Research/economicsCost-Benefit AnalysisDrug CostsFinancing, GovernmentHumansOutcome and Process Assessment, Health Care/economicsResearch Support as TopicState Medicine/economicsTreatment OutcomeUnited Kingdom
Substances： See more » Antineoplastic Agents
Year: 2014 PMID： 25638560 DOI： 10.1016/S1470-2045(14)71137-4
Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316